Zhaoke Ophthalmology to get an exclusive right to register, import, promote, distribute, market, and sell the Eye Lipid Mobilizer, a medical device for DED in Greater China (mainland China, Hong Kong, Macau, and Taiwan), South Korea & the ASEAN countries (Brunei, Cambodia, Indonesia, Laos, Malaysia, Myanmar, Philippines, Singapore, Thailand & Vietnam)
The clinical study showed compelling evidence of the efficacy of the device. A human factors research conducted in Mar 2022 revealed that ELM is intuitive and simple for patients to learn and operate
ELM will be the first and only physician-prescribed home remedy for treating the root cause of dry eye disease, upon the US FDA clearance
Ref: PRNewswire | Image: Zhaoke
Related News:- Visus Therapeutics Signs an Exclusive License Agreement with Zhaoke to Develop & Commercialize Brimochol PF and Carbachol PF for Presbyopia
PharmaShots! Your go-to media platform for customized news ranging for multiple indications. For more information connect with us at connect@pharmashots.com
